866-997-4948(US-Canada Toll Free)

Tuberculosis Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Published By :

Transparency Market Research

Published Date : Oct 2017

Category :

Biotechnology

No. of Pages : 109 Pages

Global Tuberculosis Testing Market: Overview

Tuberculosis testing can be defined as the most commonly used diagnostic tools for the tuberculosis. Tuberculosis is defined as an infectious disease which characterized by development of tubercles (nodules) in the body tissues, especially in the lungs. The market is anticipated to grow at a significant rate owing to various factors such as high return on investments, first-mover advantage to the tuberculosis test kits manufacturers, growing focus on awareness programs by the governmental and non-governmental organizations, and tax credits and fee waivers offered by the government, among others.

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of tests employed in the diagnosis of tuberculosis in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for test type, end-user, and geography for the period 2015 to 2025, considering the macro and micro environmental factors. The revenue generated from each test type, and end-user was calculated by considering the prevalence of tuberculosis, testing approvals, regulatory procedures, and the awareness of tuberculosis across all the geographies.

Global Tuberculosis Testing Market: Segmentation

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on test type, end-user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the tuberculosis testing market in the current and future scenario. The report also provides Porter’s five forces analysis, the acquisitions timeline of tuberculosis testing companies, SWOT analysis of the market, regulatory scenario, comparative analysis of tuberculosis testing policies, tuberculosis prevalence globally, pricing scenario of the tuberculosis testing, and major used tuberculosis tests.

Global Tuberculosis Testing Market: Competitive Analysis

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the tuberculosis testing market.

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the tuberculosis testing market report are Becton, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hain Lifescience GmbH, Hologic Inc., Abbott Laboratories, Alere Inc., Epistem plc, Cepheid, bioMérieux SA, Akonni Biosystems Inc., LIONEX Diagnostics & Therapeutics GmbH., Danaher Corporation, Creative Diagnostics, QIAGEN, and Oxford Immunotec Ltd. among others.

The Tuberculosis Testing Market has been segmented as follows:

Global Tuberculosis Testing Market, by Test Type

  • Chest X-Ray
  • Culture Based Tests
  • IGRA (Interferon-Gamma Release Assays)
  • Mantoux Test (TST)
  • Nucleic Acid Testing (NAT), Xpert test
  • Serological Tests
  • Smear Microscopy
  • Other Tests (ADA, etc.)

Global Tuberculosis Testing Market, by End-User, Revenue

  • Academics and Research
  • Hospitals Laboratories
  • Physician's Office Laboratories
  • Reference Laboratories
  • Others (Home Health Agencies, etc.)

Global Tuberculosis Testing Market Revenue, by Geography 

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of LATAM
  • Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of MEA

 

Table of Content

Section 1 Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Section 2 Assumptions and Research Methodology

Section 3 Executive Summary

Section 4 Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Increase in case detection rate in worldwide
4.3.1.2. Rise in prevalence of drug resistant tuberculosis infection
4.3.1.3. Improvement in bacteriological confirmation
4.3.1.4. Rise in awareness enabling proper disease management
4.3.1.5. Rising demand for improved and technologically advanced tuberculosis testing procedures
4.3.1.6. Tuberculosis awareness and control programs
4.3.2. Restraints
4.3.2.1. Challenges of Mantoux test
4.3.2.2. High cost of various tuberculosis tests
4.3.3 Opportunities
4.3.3.1. Impact of novel tests on the overall market
4.3.3.2. High potential market for affordable and more effective TB tests
4.3.4. Trends
4.5. Global Tuberculosis Testing Market Analysis and Forecasts, 2015–2025
4.6. Market Outlook
4.7. Porter's Five Forces Analysis
4.8. Burden of TB Worldwide
4.9. Burden of MDR-TB Worldwide
4.10. Challenges of Traditional Testing/Diagnostic Methods
4.11. Heat Map Analysis –Company
4.12. IGRA (Interferon Gamma Release Assay)
4.13. Smear Microscopy Tests
4.14. Nucleic Acid Testing (NAT)
4.15. Mantoux Test (Tuberculin Test)
4.16. Chest X-Ray
4.17. DST (Drug Susceptibility Testing)
4.18. Culture based method
4.19. Other Tests
4.20. Global R&D spending on Tuberculosis
4.21. Global Changes in TB R&D Funding, 2005–2015
4.22. Global R&D funding on Tuberculosis By Funders
4.23. Tuberculosis Diagnostic Tests Pipeline
4.24. An overview of progress in the development of molecular TB diagnostics
4.25. The phases of TB diagnostics development and assessment for WHO recommendation using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) process

Section 5 Global Tuberculosis Testing Market Analysis, by Test Type
5.1. Key Findings / Developments
5.2. Introduction & Definition
5.3. Global Tuberculosis Testing Market Value Share Analysis, by Test Type
5.4. Global Tuberculosis Testing Market Forecast, by Test Type
5.4.1. Chest X-Ray
5.4.2. Culture Based Tests
5.4.3. IGRA
5.4.4. Mantoux Test (TST)
5.4.5. Nucleic Acid Testing (NAT), Xpert test
5.4.6. Serological Tests
5.4.7. Smear Microscopy
5.4.8. Other Tests (ADA, etc.)
5.5. Global Tuberculosis Testing Market Attractiveness, by Test Type

Section 6 Global Tuberculosis Testing Market Analysis, by End-User
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Tuberculosis Testing Market Value Share Analysis, by End-User
6.4.1. Global Tuberculosis Testing Market Forecast, by End-user
6.4.2.1. Hospitals Laboratories
6.4.3.2. Reference Laboratories
6.4.4.3. Physician’s Office Laboratories
6.4.5.4. Academics and Research Institutes
6.4.6.5. Others (home health agencies, etc.)
6.4.7. Global Tuberculosis Testing Market Attractiveness, by End-User

Section 7 Global Tuberculosis Testing Market Analysis, by Region
7.1. Global Tuberculosis Testing Market Revenue Forecast, 2015-2025
7.2. Introduction
7.3. Global Tuberculosis Testing Market Value Share Analysis, by Region
7.4. Global Tuberculosis Testing Market Forecast, by Region
7.5. Global Tuberculosis Testing Market Attractiveness, by Region

Section 8 North America Tuberculosis Testing Market Analysis
8.1. Introduction
8.2. Key Findings
8.3. North America Tuberculosis Testing Market Overview
8.4. North America Tuberculosis Testing Market Value Share Analysis, by Country
8.4.1. U.S.
8.4.2. Canada
8.5. North America Tuberculosis Testing Market Forecast, by Country
8.6.1. North America Tuberculosis Testing Market Value Share Analysis, by Test Type
8.6.2. Chest X-Ray
8.6.3. Culture Based Tests
8.6.4. IGRA (Interferon-Gamma Release Assays)
8.6.5. Mantoux Test (TST)
8.6.6. Nucleic Acid Testing (NAT), Xpert test
8.6.6. Serological Tests
8.6.8. Smear Microscopy
8.6.9. Other Tests (ADA, etc.)
8.7. North America Tuberculosis Testing Market Forecast, by Test Type
8.8. North America Tuberculosis Testing Market Value Share Analysis, by End-User
8.8.1. Academics and Research
8.8.2. Hospitals Laboratories
8.8.3. Physician's Office Laboratories
8.8.4. Reference Laboratories
8.8.5. Others (Home Health Agencies, etc.)
8.9. North America Tuberculosis Testing Market Forecast, by End-User
8.10. North America Tuberculosis Testing Market Attractiveness Analysis

Section 9 Europe Tuberculosis Testing Market Analysis
9.1. Introduction
9.2. Key Findings
9.3. Europe Tuberculosis Testing Market Overview
9.4. Europe Tuberculosis Testing Market Value Share Analysis, by Country
9.4.1. Germany
9.4.2. U.K.
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Rest of Europe
9.5. Europe Tuberculosis Testing Market Forecast, by Country
9.6. Europe Tuberculosis Testing Market Value Share Analysis, by Test Type
9.6.1. Chest X-Ray
9.6.2. Culture Based Tests
9.6.3. IGRA (Interferon-Gamma Release Assays)
9.6.4. Mantoux Test (TST)
9.6.5. Nucleic Acid Testing (NAT), Xpert test
9.6.6. Serological Tests
9.6.7. Smear Microscopy
9.6.8. Other Tests (ADA, etc.)
9.7. Europe Tuberculosis Testing Market Forecast, by Test Type
9.8. Europe Tuberculosis Testing Market Value Share Analysis, by End-User
9.8.1. Academics and Research
9.8.2. Hospitals Laboratories
9.8.3. Physician's Office Laboratories
9.8.4. Reference Laboratories
9.8.5. Others (Home Health Agencies, etc.)
9.9. Europe Tuberculosis Testing Market Forecast, by End-User
9.10. Europe Tuberculosis Testing Market Attractiveness Analysis

Section 10 Asia Pacific Tuberculosis Testing Market Analysis
10.1. Introduction
10.2. Key Findings
10.3. Asia Pacific Tuberculosis Testing Market Overview
10.4. Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Country
10.4.1. China
10.4.2. India
10.4.3. Japan
10.4.4. Australia & New Zealand
10.4.5. Rest of Asia Pacific
10.5. Asia Pacific Tuberculosis Testing Market Forecast, by Country
10.6. Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Test Type
10.6.1. Chest X-Ray
10.6.2. Culture Based Tests
10.6.3. IGRA (Interferon-Gamma Release Assays)
10.6.4. Mantoux Test (TST)
10.6.5. Nucleic Acid Testing (NAT), Xpert test
10.6.6. Serological Tests
10.6.7. Smear Microscopy
10.6.8. Other Tests (ADA, etc.)
10.7. Asia Pacific Tuberculosis Testing Market Forecast, by Test Type
10.8. Asia Pacific Tuberculosis Testing Market Value Share Analysis, by End-User
10.8.1. Academics and Research
10.8.2. Hospitals Laboratories
10.8.3. Physician's Office Laboratories
10.8.4. Reference Laboratories
10.8.5. Others (Home Health Agencies, etc.)
10.9. Asia Pacific Tuberculosis Testing Market Forecast, by End-User
10.10. Asia Pacific Tuberculosis Testing Market Attractiveness Analysis

Section 11 Latin America Tuberculosis Testing Market Analysis
11.1. Introduction
11.2. Key Findings
11.3. Latin America Tuberculosis Testing Market Overview
11.4. Latin America Tuberculosis Testing Market Value Share Analysis, by Country
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of LATAM
11.5. Latin America Tuberculosis Testing Market Forecast, by Country
11.6. Latin America Tuberculosis Testing Market Value Share Analysis, by Test Type
11.6.1. Chest X-Ray
11.6.2. Culture Based Tests
11.6.3. IGRA (Interferon-Gamma Release Assays)
11.6.4. Mantoux Test (TST)
11.6.5. Nucleic Acid Testing (NAT), Xpert test
11.6.6. Serological Tests
11.6.7. Smear Microscopy
11.6.8. Other Tests (ADA, etc.)
11.7. Latin America Tuberculosis Testing Market Forecast, by Test Type
11.8. Latin America Tuberculosis Testing Market Value Share Analysis, by End-User
11.8.1. Academics and Research
11.8.2. Hospitals Laboratories
11.8.3. Physician's Office Laboratories
11.8.4. Reference Laboratories
11.8.5. Others (Home Health Agencies, etc.)
11.9. Latin America Tuberculosis Testing Market Forecast, by End-User
11.10. Latin America Tuberculosis Testing Market Attractiveness Analysis

Section 12 Middle East and Africa Tuberculosis Testing Market Analysis
12.1. Introduction
12.2. Key Findings
12.3. Middle East and Africa Tuberculosis Testing Market Overview
12.4. Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Country
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of MEA
12.5. Middle East and Africa Tuberculosis Testing Market Forecast, by Country
12.6. Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Test Type
12.6.1. Chest X-Ray
12.6.2. Culture Based Tests
12.6.3. IGRA (Interferon-Gamma Release Assays)
12.6.4. Mantoux Test (TST)
12.6.5. Nucleic Acid Testing (NAT), Xpert test
12.6.6. Serological Tests
12.6.7. Smear Microscopy
12.6.8. Other Tests (ADA, etc.)
12.7. Middle East and Africa Tuberculosis Testing Market Forecast, by Test Type
12.8. Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by End-User
12.8.1. Academics and Research
12.8.2. Hospitals Laboratories
12.8.3. Physician's Office Laboratories
12.8.4. Reference Laboratories
12.8.5. Others (Home Health Agencies, etc.)
12.9. Middle East and Africa Tuberculosis Testing Market Forecast, by End-User
12.10. Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis

Section 13 Region/Country Snippets

Section 14 Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.2.1. Thermo Fisher Scientific, Inc.
14.2.2. Alere, Inc.
14.2.3. Becton, Dickinson and Company
14.2.4. F. Hoffmann-La Roche AG
14.2.5. LIONEX Diagnostics & Therapeutics GmbH.
14.2.6. Danaher Corporation
14.2.7. Creative Diagnostics
14.2.8. QIAGEN
14.2.9. Hain Lifescience GmbH
14.2.10. Oxford Immunotec Ltd.
14.2.11. Hologic, Inc.
14.2.12. Cepheid
14.2.13. Akonni Biosystems, Inc.
14.2.14. bioMérieux SA
14.2.15. Epistem Ltd.

List of Table

Table 01: Top 10 High TB burden countries with estimated number of new TB cases globally 
Table 02: Estimated number of MDR-TB among all notified TB cases in high burden countries (2015)
Table 03: TB R&D Funders by Rank in 2015
Table 04: Tuberculosis Diagnostics tests Pipeline
Table 05: Global Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 06: Global Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 07: Global Tuberculosis Testing Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 09: North America Tuberculosis Testing Market Size (US$ Bn) Forecast, by Test Type, 2015–2025
Table 10: North America Tuberculosis Testing Market Size (US$ Bn) Forecast, by End-User, 2015–2025
Table 11: Europe Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 12: Europe Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 13: Europe Tuberculosis Testing Market Size (US$ Bn) Forecast, by End-User, 2015–2025
Table 14: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 15: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 16: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2015–2025
Table 17: Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 19: Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2015–2025
Table 20: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 21: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 22: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2015–2025

List of Chart

Figure 01: Global Tuberculosis Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 02: Market Value Share, by Test Type (2016)
Figure 03: Market Value Share, by End User (2016)
Figure 04: Market Value Share, by Region (2016)
Figure 05: Annual Global Plan Research Funding Targets versus 2015 Funding on Tuberculosis
Figure 06: Total TB R&D Funding, 2005–2015
Figure 07: Total TB R&D Funding by Funder Category, 2015
Figure 08: Total TB R&D Funding by Funder Category, 2005–2015 (Mn) 
Figure 09: Global Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 10: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Chest X-Ray, 2015–2025
Figure 11: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Culture Based Tests,
Figure 12: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by IGRA, 2015–2025
Figure 13: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Mantoux Test (TST), 2015–2025
Figure 14: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Nucleic Acid Testing (NAT), Xpert test, 2015–2025
Figure 15: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Serological Tests,
Figure 16: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Smear Microscopy, 2015–2025
Figure 17: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Other Tests (ADA, etc.), 2015–2025
Figure 18: Global Tuberculosis Testing Market Attractiveness, by Test Type, 2017-2025
Figure 19: Global Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
Figure 20: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2015–2025
Figure 21: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reference Laboratories, 2015–2025
Figure 22: Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Physician’s Office Laboratories, 2015–2025
Figure 23: Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academics and Research, 2015–2025
Figure 24: Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 25: Global Tuberculosis Testing Market Attractiveness, by End-User, 2017-2025
Figure 26: Global Tuberculosis Testing Market Revenue (US$ Bn) Forecast, 2015–2025
Figure 27: Global Tuberculosis Testing Market Value Share Analysis, by Region, 2016 and 2025
Figure 28: Global Tuberculosis Testing Market Attractiveness, by Region, 2017-2025
Figure 29: North America Tuberculosis Testing Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 30: North America Tuberculosis Testing Market Attractiveness Analysis, by Country, 2017–2025
Figure 31: North America Tuberculosis Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 32: North America Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 33: North America Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
Figure 34: North America Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2017–2025
Figure 35: North America Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2017–2025
Figure 36: Europe Tuberculosis Testing Market Size (US$ Bn) Forecast, 2015–2025
Figure 37: Europe Market Attractiveness Analysis, by Country, 2017–2025
Figure 38: Europe Tuberculosis Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 39: Europe Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 40: Europe Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
Figure 41: Europe Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2017–2025
Figure 42: Europe Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2017–2025
Figure 43: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 44: Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by Country, 2017–2025
Figure 45: Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 46: Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 47: Asia Pacific Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
Figure 48: Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2017–2025
Figure 49: Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2017–2025
Figure 50: Latin America Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 51: Latin America Tuberculosis Testing Market Attractiveness Analysis, by Country, 2017–2025
Figure 52: Latin America Tuberculosis Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 53: Latin America Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 54: Latin America Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
Figure 55: Latin America Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2017–2025
Figure 56: Latin America Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2017–2025
Figure 57: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn)  and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 58: Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by Country, 2017–2025
Figure 59: Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 60: Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 61: Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
Figure 62: Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2017–2025
Figure 63: Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2017–2025
Figure 64: Thermo Fisher Scientific, Inc. - Breakdown of Net Sales (% Share), by Business segments (2016)
Figure 65: Thermo Fisher Scientific, Inc. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 66: Alere, Inc. - Revenue Split, by Operating Segment, 2015
Figure 67: Alere, Inc. - Total Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016
Figure 68: Becton, Dickinson and Company - Breakdown of Net Sales, by Region, 2016
Figure 69: Becton, Dickinson and Company- Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 70: F. Hoffmann-La Roche AG Breakdown of Net Sales (Pharmaceutical Division), by Region, 2015
Figure 71: F. Hoffmann-La Roche AG- Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 72: Danaher Corporation - Breakdown of Revenue, by Region, 2016
Figure 73: Danaher Corporation - Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2016
Figure 74: QIAGEN- Breakdown of Net Sales, by Business Segment, 2016
Figure 75: QIAGEN- Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
Figure 76: Oxford Immunotec Ltd. - Breakdown of Net Sales, by region, 2015
Figure 77: Oxford Immunotec Ltd. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 78:  Hologic, Inc. - Breakdown of Net Sales, by Country/Region, 2015
Figure 79: Hologic, Inc. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2012–2015
Figure 80: Cepheid - Breakdown of Net Sales, by Country/Region, 2015
Figure 81: Cepheid - Revenue (US$ Mn) and Y-o-Y Growth (%), 2012–2015
Figure 82: bioMérieux SA - Breakdown of Net Sales, by Country/Region, 2016
Figure 83: bioMérieux SA - Revenue (US$ Mn) and Y-o-Y Growth (%), 2012–2015
Figure 84: Epistem Ltd. - Breakdown of Net Sales, by Country/Region, 2015
Figure 85: Epistem Ltd. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2012–2015

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *